IMPACT BIOTECH LTD
General Data
Reg Number
513381319
Sector
Biomed
Established
1996
No. of Employees
35
Stage
Initial Revenues
Additional Funding
1
Description
ImPact Biotech is focused on the development and launch of a drug-device combination therapy, using photodynamic technology for the treatment of solid tumors in urology, lung, and GI. The company and its manufacturing center are headquartered in Israel
Technology
- TOOKAD® is a photosensitizer, derived from palladium-substituted bacteriochlorophyll. It was designed to address limitations of previous attempts in photodynamic therapies. Through its high solubility and activation with low energy with near-infrared light, TOOKAD® enables highly localized vascular occlusion that triggers targeted necrosis of tumor lesions, while sparing surrounding healthy tissue.
- STL-6038 enables imaging and treatment of solid tumors by the same compound. The product can home in on a variety of cells in the tumor, reaching biologically relevant concentrations, while clearing from the rest of the body.
Targeted Customers
Prostate Cancer Patients, Cancer Clinics, Hospitals.
Management personnel
Winning details
Route name
Winning year
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2024